Synonyms: ARX-1796 | AV-006 | PF-07338233
Compound class:
Synthetic organic
Comment: Avibactam tomilopil is an orally available prodrug of the β-lactamase inhibitor avibactam [1]. Pfizer are developing an oral combined formulation of avibactam tomilopil and ceftibuten for the treatment of complicated urinary tract infections (cUTIs) [2].
|
|
No information available. |
Summary of Clinical Use ![]() |
Avibactam tomilopil in combination with ceftibuten is in early clinical development (Phase 1 trial, NCT05554237) as an oral treatment of cUTIs including pyelonephritis [2]. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT05554237 | A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People. | Phase 1 Interventional | Pfizer | ||
NCT03931876 | A Single Ascending Dose Study of AV-006 in Healthy Subjects | Phase 1 Interventional | Arixa Pharmaceuticals |